Amphastar Pharmaceuticals, Inc. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2024-02-29: Form 10-K; Item Well-known seasoned issuer; As filed No.
- 2023-03-01: Form 10-K; Item Well-known seasoned issuer; As filed No.
- 2022-03-11: Form 10-K; Item Well-known seasoned issuer; As filed No.
- 2021-03-15: Form 10-K; Item Well-known seasoned issuer; As filed No.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2024-02-29 | 10-K | Well-known seasoned issuer | No |
| 2023-03-01 | 10-K | Well-known seasoned issuer | No |
| 2022-03-11 | 10-K | Well-known seasoned issuer | No |
| 2021-03-15 | 10-K | Well-known seasoned issuer | No |
| 2020-03-16 | 10-K | Well-known seasoned issuer | No |
| 2019-11-08 | 10-Q | Emerging growth company | Yes |
| 2019-08-09 | 10-Q | Emerging growth company | Yes |
| 2019-05-10 | 10-Q | Emerging growth company | Yes |
| 2019-03-15 | 10-K | Emerging growth company | Yes |
| 2019-03-15 | 10-K | Well-known seasoned issuer | No |
| 2018-08-09 | 10-Q | Well-known seasoned issuer | No |
| 2018-05-10 | 10-Q | Well-known seasoned issuer | No |
| 2018-03-14 | 10-K | Well-known seasoned issuer | No |
| 2017-03-15 | 10-K | Well-known seasoned issuer | No |
| 2016-03-15 | 10-K | Well-known seasoned issuer | No |
| 2015-08-13 | 10-Q | Well-known seasoned issuer | No |
| 2015-05-14 | 10-Q | Well-known seasoned issuer | No |
| 2015-03-26 | 10-K | Well-known seasoned issuer | No |
| 2014-11-13 | 10-Q | Well-known seasoned issuer | No |
| 2014-08-13 | 10-Q | Well-known seasoned issuer | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |